Interleukin-2 Induced Changes in Mononuclear Cell Surface Charge

  • R. Jenkins
  • A. C. Williams
  • G. A. Limb
  • K. A. Brown
  • D. C. Dumonde
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 237)

Abstract

Interleukin-2 (IL-2) is not only the hormone responsible for progression of the T cell cycle, but it is also a potent activator of cytolytic (lymphokine-activated killer, LAK) activity against a wide variety of autologous and allogeneic tumours1. These effects are mediated through specific target cell membrane receptors.

Keywords

Migration Chromate Heparin Carboxyl Electrophoresis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E. A. Grimm, A. Mazunder, H. Z. Zlang, and S. A. Rosenberg, Lymphokine-activated killer cell phenomenon, J. Exp. Med. 155: 1823 (1982).PubMedCrossRefGoogle Scholar
  2. 2.
    A. W. Preece, and D. Sabolovic, eds., “Cell Electrophoresis: Clinical Application and Methodology”, North Holland, Amsterdam (1979).Google Scholar
  3. 3.
    G. M. W. Cook, D. H. Heard and G. V. F. Seaman, Sialic acids and the electrokinetic charge of the human erythrocyte, Nature 191, 44 (1961).PubMedCrossRefGoogle Scholar
  4. 4.
    R. Jenkins, P. Balding, P. Ann Light and A. W. Preece, The role of α-L-fucose in the lymphokine receptor sites of macrophages and granulocytes, in: “Cell Electrophoresis: Clinical Application and Methodology”, ibid.Google Scholar
  5. 5.
    K. A. Brown, A. W. Preece, R. A. Wolstencroft and D. C. Dumonde, Use of laser-Doppler spectroscopy for the evaluation of IL-1 and IL-2 activities, 5th International Lymphokine Workshop, Clearwater, USA, abs (1987).Google Scholar
  6. 6.
    R. Harris and E. O. Ukaejiofo, Tissue typing using a routine onestep lymphocyte separation procedure, Brit. J. Haemat., 18: 229 (1970).PubMedCrossRefGoogle Scholar
  7. 7.
    J. R. Ortaldo, G. D. Bonnard and R. B. Herberman, Cytotoxic reactivity of human lymphocytes cultured in-vitro. J. Immunol. 119: 1351 (1977)PubMedGoogle Scholar
  8. 8.
    A. W. Preece and P. Ann Light, The macrophage electrophoretic mobility (MEM) test and studies on macrophage slowing factors. Clin. Exp. Immunol. 18: 543 (1974).PubMedGoogle Scholar
  9. 9.
    D. S. B. Hoon, D. R. Wen, M. Stone, R. K. Gupta and A. J. Cochran, Inhibition of lymphocyte mobility by IL-2. Clin. Exp. Immunol., 66: 566 (1986).PubMedGoogle Scholar
  10. 10.
    G. B. Thurman, A. E. Maluish, J. L. Rossio, E. Schlick, K. Onozaki, J. E. Talmadge, A. D. G. Procopio, J. R. Ortaldo, F. W. Ruscetti, H. C. Stevenson, G. B. Cannon, S. Iyar and R. B. Herberman, Comparative evaluation of multiple lymphoid and recombinant human IL-2 preparations, J. Biol. Response Modifiers, 5: 85 (1986).Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • R. Jenkins
    • 1
  • A. C. Williams
    • 1
  • G. A. Limb
    • 1
  • K. A. Brown
    • 1
  • D. C. Dumonde
    • 1
  1. 1.Department of ImmunologyUnited Medical and Dental Schools of Guy’s and St. Thomas’ HospitalsLondonUK

Personalised recommendations